multiple myeloma
PulseAugur coverage of multiple myeloma — every cluster mentioning multiple myeloma across labs, papers, and developer communities, ranked by signal.
-
GSK licenses Chinese cancer drug for up to $750M
GSK has agreed to acquire global rights to a novel T-cell engager cancer drug from Chinese firm Chimagen Biosciences. The deal, potentially worth up to US$750 million, focuses on a treatment for multiple myeloma that ai…
-
New AI framework improves multiple myeloma lesion segmentation
Researchers have developed a novel two-stage framework for segmenting multiple myeloma lesions on whole-body diffusion-weighted imaging (WB-DWI). The first stage efficiently generates a bone region-of-interest (ROI) fro…
-
New Bayesian Method Unlocks Cancer Genomics Insights
Researchers have developed Bayesian Boolean Matrix Factorization (BBMF), a novel method for analyzing binary data, particularly in cancer genomics. Unlike existing heuristic approaches, BBMF offers a principled model wi…
-
New spBART model enhances risk prediction with high-dimensional epigenetic data
Researchers have developed a new semi-parametric Bayesian Additive Regression Trees (spBART) model to improve risk prediction using high-dimensional epigenetic data alongside lower-dimensional covariates. This method se…
-
Medical AI correctness debated in new research paper
A new paper explores the complex definition of "correctness" for AI systems in medical contexts, using the diagnosis of multiple myeloma as a case study. It argues that accuracy is not solely determined by benchmark per…
-
Agentic AI system matches expert consensus in clinical reasoning for myeloma patients
A new study evaluated an agentic reasoning system for synthesizing longitudinal clinical records in multiple myeloma management. The system achieved 79.6% concordance with expert consensus, outperforming standard retrie…